ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 777 participants.

Also called NCT01757665

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 777 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01757665
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01757665. Allocation not applicable; no masking; primary purpose treatment. Start 2012-12-11 (actual); primary completion 2017-08 (actual). Results posted on 2019-12-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
Acronym
COMMENCE
Condition
Aortic Stenosis
Condition
Mitral Stenosis
Condition
Aortic Valve Insufficiency
Condition
Mitral Valve Insufficiency
Condition
Heart Failure
Intervention (Device)
Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct01757665
Content hash
981d52bbae10dec9731b196a7dc5485c36bce0a066b962eb1ffb148a9c79274b